PMC:7253482 / 214-377 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"33","span":{"begin":153,"end":158},"obj":"Gene"}],"attributes":[{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Gene:43740568"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ns with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":72,"end":79},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"ns with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) "}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T2","span":{"begin":124,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0006959"},{"id":"T3","span":{"begin":132,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ns with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) "}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T31","span":{"begin":3,"end":7},"obj":"IN"},{"id":"T32","span":{"begin":8,"end":12},"obj":"JJ"},{"id":"T33","span":{"begin":13,"end":21},"obj":"NN"},{"id":"T34","span":{"begin":22,"end":27},"obj":"NNS"},{"id":"T35","span":{"begin":28,"end":31},"obj":"CC"},{"id":"T36","span":{"begin":32,"end":40},"obj":"JJ"},{"id":"T37","span":{"begin":41,"end":50},"obj":"NN"},{"id":"T38","span":{"begin":52,"end":59},"obj":"NN"},{"id":"T39","span":{"begin":60,"end":71},"obj":"NN"},{"id":"T40","span":{"begin":72,"end":79},"obj":"VBZ"},{"id":"T41","span":{"begin":80,"end":82},"obj":"IN"},{"id":"T42","span":{"begin":83,"end":86},"obj":"DT"},{"id":"T43","span":{"begin":87,"end":96},"obj":"JJ"},{"id":"T44","span":{"begin":97,"end":103},"obj":"NN"},{"id":"T45","span":{"begin":104,"end":106},"obj":"IN"},{"id":"T46","span":{"begin":107,"end":110},"obj":"DT"},{"id":"T47","span":{"begin":111,"end":123},"obj":"VBG"},{"id":"T48","span":{"begin":124,"end":131},"obj":"JJ"},{"id":"T49","span":{"begin":132,"end":138},"obj":"JJ"},{"id":"T50","span":{"begin":139,"end":147},"obj":"NN"},{"id":"T51","span":{"begin":147,"end":148},"obj":"-COMMA-"},{"id":"T52","span":{"begin":149,"end":152},"obj":"DT"},{"id":"T53","span":{"begin":153,"end":158},"obj":"NN"},{"id":"T54","span":{"begin":159,"end":160},"obj":"-LRB-"},{"id":"T55","span":{"begin":160,"end":161},"obj":"NN"},{"id":"T56","span":{"begin":161,"end":162},"obj":"-RRB-"}],"relations":[{"id":"R29","pred":"arg2Of","subj":"T35","obj":"T31"},{"id":"R30","pred":"arg1Of","subj":"T34","obj":"T32"},{"id":"R31","pred":"arg1Of","subj":"T34","obj":"T33"},{"id":"R32","pred":"arg1Of","subj":"T34","obj":"T35"},{"id":"R33","pred":"arg2Of","subj":"T37","obj":"T35"},{"id":"R34","pred":"arg1Of","subj":"T37","obj":"T36"},{"id":"R35","pred":"arg1Of","subj":"T39","obj":"T38"},{"id":"R36","pred":"arg1Of","subj":"T39","obj":"T40"},{"id":"R37","pred":"arg1Of","subj":"T40","obj":"T41"},{"id":"R38","pred":"arg2Of","subj":"T44","obj":"T41"},{"id":"R39","pred":"arg1Of","subj":"T44","obj":"T42"},{"id":"R40","pred":"arg1Of","subj":"T44","obj":"T43"},{"id":"R41","pred":"arg1Of","subj":"T44","obj":"T45"},{"id":"R42","pred":"arg2Of","subj":"T50","obj":"T45"},{"id":"R43","pred":"arg1Of","subj":"T50","obj":"T46"},{"id":"R44","pred":"arg1Of","subj":"T50","obj":"T47"},{"id":"R45","pred":"arg1Of","subj":"T50","obj":"T48"},{"id":"R46","pred":"arg1Of","subj":"T50","obj":"T49"},{"id":"R47","pred":"arg1Of","subj":"T50","obj":"T51"},{"id":"R51","pred":"arg1Of","subj":"T53","obj":"T54"},{"id":"R52","pred":"arg2Of","subj":"T55","obj":"T54"},{"id":"R53","pred":"arg3Of","subj":"T56","obj":"T54"}],"text":"ns with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) "}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"33","span":{"begin":153,"end":158},"obj":"Gene"}],"attributes":[{"id":"A33","pred":"pubann:denotes","subj":"33","obj":"Gene:43740568"}],"text":"ns with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) "}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T2","span":{"begin":124,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0006959"},{"id":"T3","span":{"begin":132,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ns with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) "}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T2","span":{"begin":124,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0006959"},{"id":"T3","span":{"begin":132,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ns with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":124,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0006959"},{"id":"T3","span":{"begin":132,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ns with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) "}